Treace Medical Concepts, Inc.

NASDAQ:TMCI

5.48 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -21.206-18.676-6.281-17.521-12.271-13.454-4.412-12.133-17.234-9.036-6.619-6.418-5.083-2.4322.567-2.655-1.973-1.607
Depreciation & Amortization 2.1161.9091.7691.5641.0950.9240.9170.4590.4230.3340.2760.1890.1030.1170.2080.3350.3630.304
Deferred Income Tax 00-19.61-0.367-0.326000000.3680.0350.12-0.1040.7640.7390.5140.126
Stock Based Compensation 6.747.4085.8725.1923.5962.6922.472.2691.9631.4091.2930.8390.8750.4020.3370.1250.2480.209
Change In Working Capital -3.9781.557-1.5160.781-1.169-7.864-5.7950.98-0.725-0.2660.887-3.9540.2091.528-1.481-2.796-1.050.008
Accounts Receivables 2.4767.821-13.4222.235-1.9073.793-11.097-2.054-0.432.542-6.973-1.7640.7423.769-5.056-2.767-0.2753.807
Change In Inventory -5.419-6.6150.067-3.211-3.515-3.189-2.742-3.617-1.859-0.548-0.378-2.799-0.3890.4781.338-2.15-1.23-1.36
Change In Accounts Payables -3.0769.3143.1550.5343.07-3.5920.7874.782-0.35-0.6071.614-0.4791.829-1.173-0.8081.071-0.3941.465
Other Working Capital 2.041-8.9638.6841.2231.183-4.8767.2571.8691.914-1.6536.6241.088-1.973-1.5463.0451.050.849-3.904
Other Non Cash Items 19.4221.28720.2980.8380.740.4431.4620.9420.8790.3180.0430.0450.0450.0430.0530.050.0530.065
Operating Cash Flow -13.897-7.2210.532-9.513-8.335-17.259-5.358-7.483-10.566-7.241-3.752-9.264-3.731-0.4462.448-4.202-1.845-0.895
Investing Activities:
Investments In Property Plant And Equipment -1.729-3.927-2.248-3.501-4.231-1.478-2.332-5.857-5.168-1.481-0.9-0.939-0.67-0.196-0.088-0.058-0.249-0.674
Acquisitions Net 00-7.255-8.098-200.7161.6800000000000
Purchases Of Investments 0-28.711-29.79-19.118-21.407-99.55-63.40900000000000
Sales Maturities Of Investments 24.16236.39637.04527.21635.21520.5481.72900000000000
Other Investing Activites 24.1627.6857.2558.09813.808-0.71-61.6800000000000
Investing Cash Flow 22.4333.7585.0074.597-10.423-80.48-64.012-5.857-5.168-1.481-0.9-0.939-0.67-0.196-0.088-0.058-0.249-0.674
Financing Activities:
Debt Repayment 000000-33.8930-33.8930-1.78800-1.7880-2000
Common Stock Issued 0.3110.0520.1780.1591.18107.5272.1870.3530.1651.3721.0260.041107.8040.5690000
Common Stock Repurchased 0-0.237-0.0130-6.320000000000000
Dividends Paid 0000000000-7.9350000000
Other Financing Activities 0.311-0.237-0.0130.1596.320.35232.0030.35318.7841.3721.0260.041107.804-1.2190.32329.3511.7960.033
Financing Cash Flow 0.311-0.1850.1650.1591.18107.8790.2970.35318.7841.3721.0260.041107.804-1.2190.3239.3511.7960.033
Other Information:
Effect Of Forex Changes On Cash 00-4.344-6.0089.9980000000000000
Net Change In Cash 8.847-3.6485.704-4.757-17.57810.14-69.073-12.9873.05-7.35-3.626-10.162103.403-1.8612.6835.091-0.298-1.536
Cash At End Of Period 18.1819.33412.9827.27812.03529.61319.47388.546101.53398.483105.833109.459119.62116.21818.07915.39610.30510.603